Listen Now

Dr. Paul Auwaerter discusses the effect of the Omicron variant, including its subvariants, on COVID-19 vaccines. Topics: *Impact of Omicron on mRNA boosters *Analyzing Omicron and BA.2 subvariants *Interpreting CDC vaccine data *Protection level of one-way masking  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/5-11-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul Auwaerter, MD, MBA, FIDSA, Clinical Director, Division of Infectious Diseases, Sherrilyn and Ken Fisher Professor of Medicine, Fisher Center for Environmental Infectious Diseases, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Paul G. Auwaerter, MD, MBA, FIDSA and Michael Angarone, DO, FIDSA discuss the latest guidelines for prevention of COVID-19. Topics: *Updates on the BA.2 subvariant *Who should get a second booster? And when? *What conditions and factors place people at higher risk for severe COVID? *Pre-exposure prophylaxis for COVID-19 prevention *Mitigating risk of disease progression    Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-26-22-episode/eval    Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty    Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine     Michael Angarone, DO, FIDSA, Associate Professor, Division of Infectious Diseases, Departments of Medicine and Medical Education at Northwestern University Feinberg School of Medicine See acast.com/privacy for privacy and opt-out information.

Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendations    Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine   David Klimpl, MD, Assistant Professor at University of Colorado Denver – Anschutz Medical Campus   See acast.com/privacy for privacy and opt-out information.

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questions Take our post-test to claim CME credits. To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses new vaccine boosters, global impact of the pandemic, and the BA.2 Subvariant. Topics: *New boosters in the future? *Challenges of additional boosters *Cardiac concerns with COVID-19 vaccines? *Collateral effects from the pandemic *Latest news on BA.2 Subvariant  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-13-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses what we learned from the COVID-19 pandemic. Topics: *Reviewing the timeline of events and variants *What happens next? *Preparing for the future *The new role of monoclonal antibodies  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-24-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Twenty percent of new HIV diagnoses occur among adolescents and young adults. They’re a population underserved by HIV prevention resources, with lower retention in HIV care. Their awareness and uptake of PrEP has been and remains low. What can their clinicians do to more effectively help these vulnerable young people?   Join Dr. Luis Rubio from University of California San Francisco as we explore these and other important issues in this eHIV Review podcast.  Take our post-test to claim CME credits. To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter continues his interview with Dr. Yuka Manabe about COVID-19 testing. Topics: *Future trends in infectious disease diagnostics *Closing the loop with at-home testing *Will treatment replace testing in the future? *Addressing equity of access to diagnostics  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-16-22-episode/eval     Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  Yuka Manabe, MD, Professor of Medicine, JHU School of Medicine, Medical Director, John G. Bartlett Specialty Practice, Director, Center for Innovative Diagnostics for Infectious Diseases  See acast.com/privacy for privacy and opt-out information.

Stella A. Safo, MD, MPH and Charles Vega, MD discuss how health care providers can improve access to COVID-19 treatment for people from racial/ethnic minority groups. Topics: *Who is receiving treatment for mild to moderate COVID-19? *How the social determinants of health affect COVID-19 risk *Examining COVID-19 outcomes by race and ethnicity *Improving access to treatment   Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-1-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Stella Safo, MD, MPH, Just Equity For Health, Founder and Executive Director, Assistant Professor Mount Sinai Health System   Charles Vega, MD, Clinical Professor, Family Medicine, School of Medicine   Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC), Family Medicine, School of Medicine, Associate Dean, School of Medicine at University of California, Irvine    See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter interviews Dr. Yuka Manabe about COVID-19 testing. Topics: *Evaluating COVID-19 testing methods on reliability, speed, and scale *Impact from the Omicron and other variants on testing *Differences between sample types: nasal swab vs saliva *Multiplex and the future of testing *The practical role of serology  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-9-22-episode/eval     Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  Yuka Manabe, MD, Professor of Medicine, JHU School of Medicine, Medical Director, John G. Bartlett Specialty Practice, Director, Center for Innovative Diagnostics for Infectious Diseases  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19. Topics: * Changes to NIH recommendations for mild to moderate COVID-19 * New monoclonal antibody: bebtelovimab  * Monoclonal antibody evasion in omicron sublineages * Revisions to booster dose schedules for immunocompromised people   Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-16-22-episode/eval Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Stella Safo, MD, MPH and Michael Angarone, DO, FIDSA discuss how the Omicron variant is impacting COVID-19 treatment decisions. Topics: *Are monoclonal antibodies effective against Omicron and other variants? *Prevalence of the Omicron variant *What are the other variants of concern? *Bob is 70 with lung cancer and SARS-CoV-2 positive - how can you treat him? *Addressing racial inequities      Credit available: 1.0 of AMA, ANCC, AAPA, or ACPE    Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-9-23-episode/eval Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Stella Safo, MD, MPH, Just Equity For Health, Founder and Executive Director, Assistant Professor Mount Sinai Health System    Michael Angarone, DO, FIDSA, Associate Professor, Division of Infectious Diseases, Departments of Medicine and Medical Education at Northwestern University Feinberg School of Medicine  See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses reasons to be cautiously optimistic about the future of COVID-19. Topics: *The best ways to stay protected from COVID-19 *Why Omicron is still dangerous *Danger of COVID-19 vs. seasonal flu *What we know about the BA.2 variant *Pros and cons of the Novavax vaccine  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-2-22-episode/eval    Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Paul G. Auwaerter, MD, MBA, FIDSA and Charles Vega, MD discuss the latest in COVID-19 treatment news including the Omicron variant. Topics: *Effective treatments for COVID-19 caused by Omicron variant *New antiviral, and other new and in-the-pipeline treatments *Assessing impact of COVID-19 on vulnerable populations and inequities by race/ethnicity *Q&A  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/1-25-22-episode/eval Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  Charles Vega, MD, Clinical Professor, Family Medicine, School of Medicine   Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC), Family Medicine, School of Medicine, Associate Dean, School of Medicine at University of California, Irvine    See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the COVID-19 Omicron variant. Topics: *Impact on treatment and current spread of Omicron *News on pre-exposure prophylaxis for COVID-19 prevention *With limited supply, how are patients at high risk for severe disease being treated? *Testing for Omicron  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/1-19-22-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Stella Safo, MD, MPH and Aimalohi Ahonkhai, MD, MPH discuss what we can do to address COVID-19 inequities. Topics: *New monoclonal antibody to be used to prevent infection *Latest news on the potential new oral medication *The effect of Omicron on minority populations *Explaining COVID-19 health disparities *Structural barriers to health care and vaccine access    Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/12-14-21-episode/eval     Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty    Presenting faculty:   Aimalohi Ahonkhai, MD, MPH, Assistant Professor of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center      Stella Safo, MD, MPH, Just Equity For Health, Founder and Executive Director, Assistant Professor Mount Sinai Health System  See acast.com/privacy for privacy and opt-out information.

Michael Angarone, DO, FIDSA and Charles Vega, MD discuss the latest COVID-19 treatment guidelines and recommendations. Topics: New treatments for COVID-19 Assessing impact of COVID-19 on vulnerable populations and disparities by race/ethnicity Treating patients hospitalized with COVID-19 Live Q&A Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/12-7-21-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Michael Angarone, DO, FIDSA Associate Professor Division of Infectious Diseases Departments of Medicine and Medical Education Northwestern University Feinberg School of Medicine Charles Vega, MD - Hub Faculty (Family Medicine) Clinical Professor, Family Medicine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community (PRIME-LC), Family Medicine School of Medicine Associate Dean School of Medicine University of California, Irvine See acast.com/privacy for privacy and opt-out information.

Dr. Paul Auwaerter discusses the COVID-19 variant Omicron. Topics: *Why scientists are concerned about Omicron *More transmissible than Beta and Delta? *Impact on vaccines and treatment *Origin and detection of Omicron *Holiday travel recommendations  Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/12-1-21-episode/eval   Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty  Presenting faculty:   Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine  See acast.com/privacy for privacy and opt-out information.

Shmuel Shoham, MD and Willa V. Cochran, MSN, CRNP discuss how variants are impacting COVID-19 treatment decisions. Topics: *Where are the variants of concern in the US? *Projecting future variant spread *Which monoclonal antibodies are effective for particular variants *Facilitating treatment with monoclonal antibodies  Credit available: 1.0 of AMA, ANCC, AAPA, or ACPE    Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/11-17-21-episode/eval     Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty    Presenting faculty:   Shmuel Shoham, MD, Associate Professor of Medicine, Associate Director of Transplant and Oncology Infectious Diseases Program at Johns Hopkins University School of Medicine       Willa V. Cochran, MSN, CRNP, Infectious Disease Nurse Practitioner at Johns Hopkins Hospital, Comprehensive Transplant Center  See acast.com/privacy for privacy and opt-out information.